Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | DPP4 | P27487 | 2/20 | 0.49 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.49 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.49 |
| ▸ | LTA4H | P09960 | 3/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.37 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL716803 | 1.00 | ALOX15 (0.56) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL10192702 | 1.00 | ALOX15 (0.56) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL2082961 | 1.00 | ALOX15 (0.56) | ALOX15BLMPMP22KMT2ADPP4 | |
| Hydrochloric Acid SCHEMBL595131 | 0.98 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2ADPP4 | |
| Hydrochloric Acid SCHEMBL2083204 | 0.98 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL10633429 | 0.91 | ALOX15 (0.47) | ALOX15BLMPMP22KMT2ADPP4 | |
| Glutamic Acid SCHEMBL19128265 | 0.88 | ALOX15 (0.63) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL11776470 | 0.84 | SMN1; SMN2 (0.42) | LTA4HSLC1A1CA1CA2SMN1; SMN2 | |
| SCHEMBL12601005 | 0.83 | LTA4H (0.40) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL18870212 | 0.83 | ALOX15 (0.52) | ALOX15BLMPMP22KMT2ADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 435 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116199643-A | Phenothiazine compound containing isopropanol substructure, and preparation and application thereof | 贵州大学 | 2023-06-02 | — | — | CN | claimed |
| CN-110407807-A | A kind of preparation method of lenalidomide | GANSU TAISHENG CHEMICAL TECH CO LTD | 2019-11-05 | — | — | CN | claimed |
| CN-102892425-A | Treatment of cardiac conditions | ZEALAND PHARMA AS | 2013-01-23 | — | — | CN | claimed |
| CN-101116654-B | Use of ellagic acid for treating whitening of the hair | OREAL | 2012-11-21 | — | — | CN | claimed |
| CN-101591375-B | Compound with analgesic activity, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2011-11-09 | — | — | CN | claimed |
| CN-101190895-B | N-[(3S)-1,2,3,4-tetrahydroisoquinolino-3-formacyl]amino acid, preparation method and application thereof | CAPITAL UNIVERSITY OF MEDICAL SCIENCES | 2010-05-26 | — | — | CN | claimed |
| CN-101665484-A | Method for preparing lenalidomide | SHANGHAI HAOYUAN CHEMEXPRESS B | 2010-03-10 | — | — | CN | claimed |
| CN-101591375-A | Has compound of analgesic activities and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-02 | — | — | CN | claimed |
| CN-1429097-A | Use of ellagic acid as anti-pollution cosmetic agent | OREAL (FR) | 2003-07-09 | — | — | CN | claimed |
| EP-4673146-A2 | METHODS FOR TREATING OBSESSIVE COMPULSIVE RELATED DISORDERS, TIC DISORDERS AND GLUTAMATE EXCITOTOXICITY RELATED DISORDERS | Biohaven Therapeutics Ltd. (VG) | 2026-01-07 | — | — | EP | disclosed |
| US-20250381155-A1 | USE OF 2-HYDROXYBENZYLAMINE IN THE TREATMENT AND PREVENTION OF PULMONARY HYPERTENSION | UNIV VANDERBILT (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4662213-A1 | SUBSTITUTED PYRAZOLO-PYRIMIDINES AND USES THEREOF | Verge Analytics, Inc. (US) | 2025-12-17 | — | — | EP | disclosed |
| US-20250376443-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION (US) | 2025-12-11 | — | — | US | disclosed |
| US-12492280-B2 | Process for producing a polyurethane composition | BASF SE (DE) | 2025-12-09 | — | — | US | disclosed |
| US-5350748-A | 3-thio or amino substituted-benzo[b]thiophene-2-carboxamides and 3-oxygen, thio, or amino substituted-benzofuran-2-carboxamides as inhibitors of cell adhesion | WARNER-LAMBERT COMPANY (US) | 1994-09-27 | — | — | US | disclosed |
| CN-1079473-A | The N-phosphinylidyne small peptide | UNIV QINGHUA (CN) | 1993-12-15 | — | — | CN | disclosed |
| EP-0485517-A1 | SYNTHESIS OF GLYCOSIDES HAVING PREDETERMINED STEREOCHEMISTRY | YALE UNIVERSITY (US) | 1992-05-20 | — | — | EP | disclosed |
| WO-1991002739-A1 | SYNTHESIS OF GLYCOSIDES HAVING PREDETERMINED STEREOCHEMISTRY | YALE UNIVERSITY (US) | 1991-03-07 | — | — | WO | disclosed |
| US-4766110-A | INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS | RYAN JAMES W (US) | 1988-08-23 | — | — | US | disclosed |
| EP-0073143-A2 | Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides | Ryan, James Walter (US) | 1983-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250376443-A1 | MASP-2 INHIBITORS AND METHODS OF USE | MASP2, METAP2, SPINT2 | ALOX15 4053/4885BLM 1482/4885PMP22 3333/4885 |
| US-20250381155-A1 | USE OF 2-HYDROXYBENZYLAMINE IN THE TREATMENT AND PREVENTION OF PULMONARY HYPERTENSION | SIRT3, SIRT2, GLS | ALOX15 2840/4885BLM 2932/4885PMP22 2393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.